Tokyo Tape
Sign in
← Muromachi Chemicals

Half-year report · HY

4885.TEDINET S100XFQT
Period2025-06-01 → 2025-11-30
Filed2026-01-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 50
MetricValuePeriodScopeSource row
Revenue¥3.7bn2025-06-01 → 2025-11-30StandaloneNet sales
Revenue¥6.7bn2024-06-01 → 2025-05-31StandaloneNet sales (5-year summary)
Revenue¥3.0bn2024-06-01 → 2024-11-30StandaloneNet sales
Operating income¥349m2025-06-01 → 2025-11-30StandaloneOperating income
Operating income¥154m2024-06-01 → 2024-11-30StandaloneOperating income
Ordinary income¥337m2025-06-01 → 2025-11-30StandaloneOrdinary income
Ordinary income¥430m2024-06-01 → 2025-05-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥171m2024-06-01 → 2024-11-30StandaloneOrdinary income
Profit before tax¥336m2025-06-01 → 2025-11-30StandaloneIncome before income taxes
Profit before tax¥171m2024-06-01 → 2024-11-30StandaloneIncome before income taxes
Net income¥244m2025-06-01 → 2025-11-30StandaloneProfit loss
Net income¥241m2024-06-01 → 2025-05-31StandaloneNet income loss (5-year summary)
Net income¥121m2024-06-01 → 2024-11-30StandaloneProfit loss
Total assets¥6.5bnat 2025-11-30StandaloneAssets
Total assets¥5.3bnat 2025-05-31StandaloneAssets
Total assets¥5.5bnat 2024-11-30StandaloneTotal assets (5-year summary)
Total liabilities¥3.8bnat 2025-11-30StandaloneLiabilities
Total liabilities¥2.8bnat 2025-05-31StandaloneLiabilities
Net assets / equity¥2.7bnat 2025-11-30StandaloneNet assets
Net assets / equity¥2.5bnat 2025-05-31StandaloneNet assets
Net assets / equity¥2.3bnat 2024-11-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.9bnat 2025-11-30StandaloneCash and deposits
Cash and deposits¥1.1bnat 2025-05-31StandaloneCash and deposits
Cash & equivalents¥1.8bnat 2025-11-30StandaloneCash and cash equivalents
Cash & equivalents¥1.0bnat 2025-05-31StandaloneCash and cash equivalents
Cash & equivalents¥1.3bnat 2024-11-30StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2024-05-31vStandaloneCash and cash equivalents
Operating cash flow¥282m2025-06-01 → 2025-11-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥216m2024-06-01 → 2025-05-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥137m2024-06-01 → 2024-11-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥141m2025-06-01 → 2025-11-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥371m2024-06-01 → 2025-05-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥188m2024-06-01 → 2024-11-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥672m2025-06-01 → 2025-11-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥123m2024-06-01 → 2025-05-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥336m2024-06-01 → 2024-11-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥60.852025-06-01 → 2025-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥60.422024-06-01 → 2025-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥30.292024-06-01 → 2024-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥59.982025-06-01 → 2025-11-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥59.492024-06-01 → 2025-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥29.822024-06-01 → 2024-11-30StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥102025-06-01 → 2025-11-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥252024-06-01 → 2025-05-31StandaloneDividend paid per share (5-year summary)
Equity ratio41.0%at 2025-11-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio46.6%at 2025-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio42.2%at 2024-11-30StandaloneEquity to asset ratio (5-year summary)
Shares issued4,095,500at 2025-11-30StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2025-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2024-11-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
Chemical Products Businessreportable segmentrevenue2025-06-01 → 2025-11-30¥1.3bn
Chemical Products Businessreportable segmentrevenue external2025-06-01 → 2025-11-30¥1.3bn
Chemical Products Businessreportable segmentsegment profit2025-06-01 → 2025-11-30¥58m
Healthy Food Businessreportable segmentrevenue2025-06-01 → 2025-11-30¥660m
Healthy Food Businessreportable segmentrevenue external2025-06-01 → 2025-11-30¥660m
Healthy Food Businessreportable segmentsegment profit2025-06-01 → 2025-11-30¥6m
Pharmaceutical Businessreportable segmentrevenue2025-06-01 → 2025-11-30¥1.8bn
Pharmaceutical Businessreportable segmentrevenue external2025-06-01 → 2025-11-30¥1.8bn
Pharmaceutical Businessreportable segmentsegment profit2025-06-01 → 2025-11-30¥285m
—segment totalrevenue2025-06-01 → 2025-11-30¥3.7bn
—segment totalrevenue external2025-06-01 → 2025-11-30¥3.7bn
—segment totalsegment profit2025-06-01 → 2025-11-30¥349m
Chemical Products Businessreportable segmentrevenue2024-06-01 → 2024-11-30¥1.1bn
Chemical Products Businessreportable segmentrevenue external2024-06-01 → 2024-11-30¥1.1bn
Chemical Products Businessreportable segmentsegment profit2024-06-01 → 2024-11-30−¥17m
Healthy Food Businessreportable segmentrevenue2024-06-01 → 2024-11-30¥523m
Healthy Food Businessreportable segmentrevenue external2024-06-01 → 2024-11-30¥523m
Healthy Food Businessreportable segmentsegment profit2024-06-01 → 2024-11-30¥5m
Pharmaceutical Businessreportable segmentrevenue2024-06-01 → 2024-11-30¥1.4bn
Pharmaceutical Businessreportable segmentrevenue external2024-06-01 → 2024-11-30¥1.4bn
Pharmaceutical Businessreportable segmentsegment profit2024-06-01 → 2024-11-30¥167m
—segment totalrevenue2024-06-01 → 2024-11-30¥3.0bn
—segment totalrevenue external2024-06-01 → 2024-11-30¥3.0bn
—segment totalsegment profit2024-06-01 → 2024-11-30¥154m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 490
ItemContextValueUnit
Other clInterimInstant_NonConsolidatedMember301984000JPY
Current liabilitiesPrior1YearInstant_NonConsolidatedMember1455333000JPY
Current liabilitiesInterimInstant_NonConsolidatedMember1935749000JPY
Long term loans payablePrior1YearInstant_NonConsolidatedMember1240400000JPY
Long term loans payableInterimInstant_NonConsolidatedMember1766148000JPY
Provision for retirement benefitsPrior1YearInstant_NonConsolidatedMember29033000JPY
Provision for retirement benefitsInterimInstant_NonConsolidatedMember29940000JPY
Asset retirement obligations nclPrior1YearInstant_NonConsolidatedMember53731000JPY
Asset retirement obligations nclInterimInstant_NonConsolidatedMember53954000JPY
Long term accounts payable otherPrior1YearInstant_NonConsolidatedMember30880000JPY
Long term accounts payable otherInterimInstant_NonConsolidatedMember30880000JPY
Other nclPrior1YearInstant_NonConsolidatedMember3413000JPY
Other nclInterimInstant_NonConsolidatedMember2854000JPY
Noncurrent liabilitiesPrior1YearInstant_NonConsolidatedMember1357458000JPY
Noncurrent liabilitiesInterimInstant_NonConsolidatedMember1883777000JPY
LiabilitiesPrior1YearInstant_NonConsolidatedMember2812792000JPY
LiabilitiesInterimInstant_NonConsolidatedMember3819526000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember143172000JPY
Capital stockInterimInstant_NonConsolidatedMember143172000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember677365000JPY
Capital surplusInterimInstant_NonConsolidatedMember686007000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember1546754000JPY
Retained earningsInterimInstant_NonConsolidatedMember1690678000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-27594000JPY
Treasury stockInterimInstant_NonConsolidatedMember-21021000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember2339697000JPY
Shareholders equityInterimInstant_NonConsolidatedMember2498836000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember112084000JPY
Valuation difference on available for sale securitiesInterimInstant_NonConsolidatedMember151473000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember112084000JPY
Valuation and translation adjustmentsInterimInstant_NonConsolidatedMember151473000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember2451781000JPY
Net assetsInterimInstant_NonConsolidatedMember2650309000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember5264574000JPY
Liabilities and net assetsInterimInstant_NonConsolidatedMember6469836000JPY
Net salesPrior1InterimDuration_NonConsolidatedMember2965030000JPY
Net salesInterimDuration_NonConsolidatedMember3681857000JPY
Cost of salesPrior1InterimDuration_NonConsolidatedMember2075682000JPY
Cost of salesInterimDuration_NonConsolidatedMember2552686000JPY
Gross profitPrior1InterimDuration_NonConsolidatedMember889347000JPY
Gross profitInterimDuration_NonConsolidatedMember1129170000JPY
Salaries and allowances sgaPrior1InterimDuration_NonConsolidatedMember256992000JPY
Salaries and allowances sgaInterimDuration_NonConsolidatedMember247946000JPY
Legal welfare expenses sgaPrior1InterimDuration_NonConsolidatedMember54180000JPY
Legal welfare expenses sgaInterimDuration_NonConsolidatedMember54757000JPY
Provision for bonuses sgaPrior1InterimDuration_NonConsolidatedMember58620000JPY
Provision for bonuses sgaInterimDuration_NonConsolidatedMember58822000JPY
Retirement benefit expenses sgaPrior1InterimDuration_NonConsolidatedMember9640000JPY
Retirement benefit expenses sgaInterimDuration_NonConsolidatedMember9473000JPY
Share based compensation expenses sgaPrior1InterimDuration_NonConsolidatedMember2556000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2025-05-31pass rounding
balance sheet identitynon_consolidated 2025-11-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2025-05-31pass
statement vs summary · net assetsnon_consolidated 2025-11-30pass
statement vs summary · operating cash flownon_consolidated 2024-06-01/2024-11-30pass
statement vs summary · operating cash flownon_consolidated 2025-06-01/2025-11-30pass
statement vs summary · revenuenon_consolidated 2024-06-01/2024-11-30pass
statement vs summary · revenuenon_consolidated 2025-06-01/2025-11-30pass
statement vs summary · total assetsnon_consolidated 2025-05-31pass
statement vs summary · total assetsnon_consolidated 2025-11-30pass